Assessing the effects of caffeine and theanine on the maintenance of vigilance during a sustained attention task
about
Cumulative neurobehavioral and physiological effects of chronic caffeine intake: individual differences and implications for the use of caffeinated energy productsIntake of green tea inhibited increase of salivary chromogranin A after mental task stress loadsEffects of concurrent caffeine and mobile phone exposure on local target probability processing in the human brain.Anti-Stress, Behavioural and Magnetoencephalography Effects of an L-Theanine-Based Nutrient Drink: A Randomised, Double-Blind, Placebo-Controlled, Crossover TrialBehavioural effects of compounds co-consumed in dietary forms of caffeinated plants.Criteria for validation and selection of cognitive tests for investigating the effects of foods and nutrients.Influence of energy drink ingredients on mood and cognitive performance.Acute effects of dietary constituents on motor skill and cognitive performance in athletes.Exploring the unknown: electrophysiological and behavioural measures of visuospatial learning.Effects of green and black tea consumption on brain wave activities in healthy volunteers as measured by a simplified Electroencephalogram (EEG): A feasibility study.Working towards a test for screening visual skills in a complex visual environment.Caffeine and theanine exert opposite effects on attention under emotional arousal.Anxiety-mediated facilitation of behavioral inhibition: Threat processing and defensive reactivity during a go/no-go task.Effects of chronic l-theanine administration in patients with major depressive disorder: an open-label study.Behavioral profile assessment in offspring of Swiss mice treated during pregnancy and lactation with caffeine.Acute effects of theanine, caffeine and theanine-caffeine combination on attention.Biofeedback-based self-alert training reduces alpha activity and stabilizes accuracy in the Sustained Attention to Response Task.Effects of Soft Drinks on Resting State EEG and Brain-Computer Interface Performance.
P2860
Q28392222-A81DD1C7-746C-4D11-B7C1-30F71FF036DEQ33987926-3FF34B35-0C3C-46A4-B8B4-D525F1B81C83Q36099386-52495E29-8CE1-49D2-865B-5BD93F6FA5B9Q36507543-EE9F4A87-3CD8-4226-A67F-EFC933029C76Q38096544-5C64EEAB-7F5D-472D-9104-337D559E05C2Q38201766-A7F6F08C-CA3A-4471-B769-A67131DF7E88Q38257905-049438E8-98CA-4928-A524-6B9F76157355Q38268570-A493C257-6C22-41A5-B79F-98C00CB1B1A1Q40028094-DA469DB6-2089-490F-9903-AB64D35D02B0Q41352225-3A54D52B-61FC-4F42-BB9F-E687078A935AQ45901660-24734A58-707A-4EE4-8E07-78CAA822B822Q47357585-32CF0E58-16F7-4F6B-9B4B-00C2DFDAE9F7Q47391397-0C815AC6-8EFA-4A2B-8F10-F25CF2D0A18BQ47412293-24953BF0-17AE-46BD-8ACD-C7830D4B0E61Q47423605-7728DC28-3163-4098-B011-FDBCFD297359Q48240425-EC50A650-253F-4FDC-992A-36FE0E15CB5DQ48340919-6B5FFE4C-285B-4E3B-BE08-BB11C4384688Q52697261-7E3BF914-FE29-48E7-9FE4-AFC71A9B8AA4
P2860
Assessing the effects of caffeine and theanine on the maintenance of vigilance during a sustained attention task
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Assessing the effects of caffe ...... ing a sustained attention task
@ast
Assessing the effects of caffe ...... ing a sustained attention task
@en
Assessing the effects of caffe ...... ing a sustained attention task
@nl
type
label
Assessing the effects of caffe ...... ing a sustained attention task
@ast
Assessing the effects of caffe ...... ing a sustained attention task
@en
Assessing the effects of caffe ...... ing a sustained attention task
@nl
prefLabel
Assessing the effects of caffe ...... ing a sustained attention task
@ast
Assessing the effects of caffe ...... ing a sustained attention task
@en
Assessing the effects of caffe ...... ing a sustained attention task
@nl
P2093
P50
P1433
P1476
Assessing the effects of caffe ...... ing a sustained attention task
@en
P2093
Eveline A de Bruin
Kristen P Morie
Matthew J Rowson
P304
P356
10.1016/J.NEUROPHARM.2012.01.020
P407
P577
2012-02-02T00:00:00Z